DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Wells Fargo Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $189

Wells Fargo maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $186 to $189.

Benzinga · 01/22/2020 14:07

Wells Fargo maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $186 to $189.